Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
Open Access
- 3 May 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (5) , e193613
Abstract
Chronic hepatitis C virus (HCV) infection is a global health problem that affects 70 million people worldwide.1 It is associated with a substantial morbidity and mortality burden, and in 2015, approximately 400 000 people died of HCV infection. Pakistan has a generalized epidemic of HCV infection and one of the highest prevalence rates (4.9%) in the world, with 8 million to 11 million individuals with active HCV viremia.1,2 Furthermore, most HCV-infected individuals in Pakistan remain undiagnosed.2 Most HCV infections in Pakistan are transmitted through unsafe medical practices, especially reuse of injection equipment in the health care setting.3 In addition, people who inject drugs, although a small proportion of the population, have a high prevalence of infection, ranging from 40% to 90%.4,5Keywords
This publication has 26 references indexed in Scilit:
- Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antiviralsHepatology, 2016
- Strategies to manage hepatitis C virus infection disease burden – volume 3Journal of Viral Hepatitis, 2015
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesAnnals of Internal Medicine, 2015
- The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based PredictionsAnnals of Internal Medicine, 2014
- HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data SynthesisPLOS Medicine, 2014
- The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care SettingsAnnals of Internal Medicine, 2012
- Trends in Organ Donation and Transplantation in the United States, 1999-2008American Journal of Transplantation, 2010
- Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infectionHepatology, 2008
- Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patientsJournal of Hepatology, 2004
- Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGastroenterology, 1997